MDA-7/IL-24 inhibits cell survival by inducing apoptosis in nasopharyngeal carcinoma

被引:2
|
作者
Lin, Cheng [2 ]
Liu, Haibin [1 ]
Li, Li [1 ]
Zhu, Qiubei [1 ]
Liu, Huanhai [1 ]
Ji, Zhenghua [1 ]
Liao, Jianchun [1 ]
Lang, Juntian [1 ]
Wu, Jian [1 ]
Fan, Jingping [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200003, Peoples R China
[2] 452 Hosp, Dept Otolaryngol Head & Neck Surg, Chengdu 610021 1, Peoples R China
关键词
MDA-7/IL-24; nasopharyngeal carcinoma; cell survival; DIFFERENTIATION-ASSOCIATED GENE-7; MELANOMA-DIFFERENTIATION; TUMOR-SUPPRESSOR; CANCER CELLS; XENOGRAFT TUMORS; MDA-7; GENE; PHASE-I; EXPRESSION; FAMILY; GROWTH;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: Nasopharyngeal carcinoma (NPC) is the most common primary malignancy of the nasopharynx. Due to its local recurrence and distant metastasis, conventional therapy is usually ineffective. MDA-7/IL-24 (melanoma differentiation associated gene 7), a member of the IL10 family of cytokines, inhibits growth of various human cancer cells, but the underlying mechanism is largely unknown. There is no report of mda-7 in nasopharyngeal carcinoma. We aimed to investigate the role of MDA-7/IL-24 in NPC. Methods: Immune defective adenoviral vector carrying the gene was produced, infected NPC CNE cells and observed its growth, cell proliferation, apoptosis and the effect of combination with chemotherapy. Results: The results showed that (1) MDA-7/IL-24 inhibited NPC CNE cell growth and survival; (2) mda-7 induced cell apoptosis and death; (3) MDA-7/IL-24 in collaboration with chemotherapy induced cell apoptosis significantly; (4) MDA-7/IL-24 induced cell apoptosis by down-regulation of anti-apoptosis molecules such as Bcl-2 and Bcl-xl and up-regulation of caspase 3. Conclusion: The results suggested that MDA-7/IL-24 had obvious therapeutic effect in NPC cells. It is verified that adenovirus mediated MDA-7/IL-24 represents a potentially important new approach to NPC therapy.
引用
收藏
页码:4082 / 4090
页数:9
相关论文
共 50 条
  • [41] The apoptosis enhancement effect of IL-24/mda-7 (melanoma differentiation associated gene-7) by fusion with RGD peptide, on a hepatocellular carcinoma related cell
    Hosseini, S. Y.
    Hosseini, E.
    Sadeghizadeh, M.
    Hashempour, T.
    Kalani, M.
    Fattahi, M. R.
    HUMAN GENE THERAPY, 2016, 27 (11) : A93 - A93
  • [42] MDA-7/IL-24: A NOVEL GENE DRUG FOR HUMAN CANCER THERAPY
    Ramesh, Rajagopal
    Shanker, Manish
    Yokoyama, Tomohisa
    Branch, Cynthia D.
    Zheng, Mingzhong
    Scott, Ailing W.
    Jin, Jiankin
    Bocange, Dora
    Chada, Sunil
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3458 - 3459
  • [43] MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity
    Gopalan, B.
    Shanker, M.
    Scott, A.
    Branch, C. D.
    Chada, S.
    Ramesh, R.
    CANCER GENE THERAPY, 2008, 15 (01) : 1 - 8
  • [44] Tumour suppressor function of MDA-7/IL-24 in human breast cancer
    Neill Patani
    Anthony Douglas-Jones
    Robert Mansel
    Wen Jiang
    Kefah Mokbel
    Cancer Cell International, 10
  • [45] MDA-7/IL-24蛋白的功能研究进展
    崔迎彬
    陈虹
    黄秉仁
    中国医药生物技术, 2007, (02) : 139 - 141
  • [46] IL-24/MDA-7 Suppressed the Transplantation Tumor in BALB/c Mice
    Jiancheng Xue1
    Cellular & Molecular Immunology, 2006, (05) : 385 - 390
  • [47] Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy
    Jiang, Guan
    Zhang, Lei
    Xin, Yong
    Pei, Dong-Sheng
    Wei, Zhi-Ping
    Liu, Yan-Qun
    Zheng, Jun-Nian
    ACTA ONCOLOGICA, 2012, 51 (03) : 285 - 292
  • [48] Tumour suppressor function of MDA-7/IL-24 in human breast cancer
    Patani, Neill
    Douglas-Jones, Anthony
    Mansel, Robert
    Jiang, Wen
    Mokbel, Kefah
    CANCER CELL INTERNATIONAL, 2010, 10
  • [49] 抑癌基因mda-7/IL-24与肿瘤治疗
    钱军
    林江
    临床与病理杂志, 2003, (03) : 251 - 254
  • [50] Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma
    Leath, CA
    Kataram, M
    Bhagavatula, P
    Gopalkrishnan, RV
    Dent, P
    Fisher, PB
    Pereboev, A
    Carey, D
    Lebedeva, IV
    Haisma, HJ
    Alvarez, RD
    Curiel, DT
    Mahasreshti, PJ
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 352 - 362